Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
6.34
+0.26 (4.28%)
Aug 30, 2024, 4:00 PM EDT - Market closed
Applied Therapeutics Employees
Applied Therapeutics had 25 employees as of December 31, 2023. The number of employees decreased by 2 or -7.41% compared to the previous year.
Employees
25
Change (1Y)
-2
Growth (1Y)
-7.41%
Revenue / Employee
n/a
Profits / Employee
-$6,443,560
Market Cap
728.13M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Community Health Systems | 61,000 |
CureVac | 1,172 |
Exscientia | 483 |
Wave Life Sciences | 268 |
Simulations Plus | 197 |
Mesoblast | 83 |
Arbutus Biopharma | 73 |
Savara | 37 |
APLT News
- 4 weeks ago - Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside - Benzinga
- 2 months ago - Applied Therapeutics Added to Russell 3000® Index - GlobeNewsWire
- 2 months ago - Top 4 Health Care Stocks That May Keep You Up At Night This Month - Benzinga
- 3 months ago - Applied Therapeutics: A Strong Buy With AT-007 Nearing Approval For Galactosemia - Seeking Alpha
- 4 months ago - Applied Therapeutics Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer - GlobeNewsWire
- 5 months ago - US FDA extends review of Applied Therapeutics' genetic disease drug - Reuters
- 5 months ago - Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia - GlobeNewsWire